FENC
Fennec Pharmaceuticals Inc. (FENC)
NASDAQ · Healthcare
Fennec Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fennec Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 15.1 M, a 72.64% increase year-over-year.
- Fennec Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 46.0 M, a 0.34% decrease year-over-year.
- Fennec Pharmaceuticals Inc. annual revenue for 2025 was 44.6 M, a 6.09% decrease from 2024.
- Fennec Pharmaceuticals Inc. annual revenue for 2024 was 47.5 M, a 123.69% increase from 2023.
- Fennec Pharmaceuticals Inc. annual revenue for 2023 was 21.3 M, a 1284.50% increase from 2022.
- Fennec Pharmaceuticals Inc. annual revenue for 2022 was 1.5 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Fennec Pharmaceuticals Inc. Market Cap — FAQ
Fennec Pharmaceuticals Inc. (FENC) market cap over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FENC's market cap history?
The chart and table above show Fennec Pharmaceuticals Inc.'s market cap by year and by quarter, including the growth rate.